Rankings
▼
Calendar
PASG
Passage Bio, Inc.
$28M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$8M
EPS (Diluted)
$-6.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$214,000
Free Cash Flow
-$1M
Stock-Based Comp.
$231,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$31M
Cash & Equivalents
-$25M
← FY 2019
All Quarters
Q2 2019 →
PASG Q1 2019 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
